Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Effects of thrombin inhibitor with or without gpIIb/IIIa antagonist during coronary thrombolysis

July 3, 1997

Topical t-PA for the treatment of venous ulcers

July 2, 1997

Synthesis and pharmacological profile of new antithrombotic pentasaccharide

July 2, 1997

Cell Genesys reports encouraging preclinical results of gene therapy for hemophilia

July 1, 1997

ReoPro safe and effective in high-risk PTCA patients

July 1, 1997

Modified t-PA from Eisai highly effective thrombolytic

July 1, 1997

TIMI-IIA finds enoxaparin promising

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Thrombin inhibitors from Akzo Nobel

June 27, 1997

Orally active antithrombotic agents described by Pfizer

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...